MindWalk (HYFT) Registration Filing summary

Company overview and business model

• Operates in the biotechnology sector, focusing on antibody discovery and development services for pharmaceutical and biotech clients.

• Headquartered in Victoria, British Columbia, with operations in the US and Canada.

• Common shares are listed on the NASDAQ Capital Market under the symbol "IPA."

Financial performance and metrics

• As of April 30, 2024, 26,944,500 common shares were outstanding, with 27,302,260 shares issued and outstanding as of July 29, 2024.

• No convertible debentures were outstanding as of April 30, 2024.

Use of proceeds and capital allocation

• Will not receive any proceeds from the resale of shares by the selling shareholder; all proceeds go to the selling shareholder.

• Expenses related to registration (excluding brokerage fees and commissions) will be borne by the company, estimated at $62,339.